Shiyue Xu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Sam68 Exacerbates Pathologic Cardiac Hypertrophy by Suppressing Cardiomyocyte Glucose Oxidation.
Journal: Circulation
Published: May 22, 2026
Sam68 Exacerbates Pathologic Cardiac Hypertrophy by Suppressing Cardiomyocyte Glucose Oxidation.
Journal: Circulation
Published: May 22, 2026
Chiral sodium complex-catalyzed asymmetric cascade cycloaddition/hydration/1,2-rearrangement.
Journal: Science advances
Published: December 12, 2025
Inflammatory Gene Signature Identified by Machine Algorithms Reveals Novel Biomarkers of Coronary Artery Disease.
Journal: Journal of inflammation research
Published: October 30, 2024
Trimethylamine-N-Oxide Impedes Late Endothelial Progenitor Cell-Mediated Revascularization by Triggering Mitochondrial Apoptosis via Suppression of MnSOD.
Journal: Cardiovascular therapeutics
Published: July 15, 2024
Alkenyl oxindole is a novel PROTAC moiety that recruits the CRL4DCAF11 E3 ubiquitin ligase complex for targeted protein degradation.
Journal: PLoS biology
Published: January 31, 2024
Enantioselective Synthesis of N-N Amide-Pyrrole Atropisomers via Paal-Knorr Reaction.
Journal: Organic letters
Published: December 18, 2023
Design and synthesis of dual BRD4/Src inhibitors for treatment of triple-negative breast cancer.
Journal: European journal of medicinal chemistry
Published: November 03, 2023
NAD+ exhaustion by CD38 upregulation contributes to blood pressure elevation and vascular damage in hypertension.
Journal: Signal transduction and targeted therapy
Published: December 05, 2022
Organocatalytic Enantioselective Construction of Spiroketal Lactones Bearing Axial and Central Chirality via an Asymmetric Domino Reaction.
Journal: Organic letters
Published: April 05, 2022
Organocatalytic enantioselective construction of axially chiral (1H)-isochromen-1-imines.
Journal: Organic & biomolecular chemistry
Published: April 04, 2022
Gentiopicroside Ameliorates Diabetic Renal Tubulointerstitial Fibrosis via Inhibiting the AT1R/CK2/NF-κB Pathway.
Journal: Frontiers in pharmacology
Published: January 05, 2022
Last Updated: 09/26/2026